Skip to content

Automatic Segmentation Ultrasound-based Radiomics Technology in Diabetic Kidney Disease

Noninvasive Detection of Diabetic Kidney Disease Based on Automatic Segmentation Ultrasound-based Radiomics Technology

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05025540
Enrollment
499
Registered
2021-08-27
Start date
2021-06-01
Completion date
2021-12-01
Last updated
2022-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Kidney Disease

Keywords

diabetic kidney disease, ultrasound, radiomics, deep learning, multi-center

Brief summary

Diabetic kidney disease is a common complication of diabetes and the main cause of end-stage renal disease. In this study, the investigator plan to enroll nearly 500 participant with/without DKD and to develop an automatic segmentation ultrasound based radiomics technology to differentiating participant with a non-invasive and an available way.

Detailed description

Ultrasound examination is a convenient, cheap and non-invasive method for kidney examination. However, the ability of conventional ultrasound to distinguish diabetic kidney disease from normal kidney is limited, and it is difficult to accurately distinguish between diabetic kidney disease and normal kidney only with the naked eye. In recent years, computer science has developed rapidly and artificial intelligence has been developing continuously. Much progress has been made in applying artificial intelligence in data analysis. Machine learning is a direction of generalized artificial intelligence, its main characteristic is to make the machine autonomous prediction and create algorithm, so as to achieve autonomous learning. kidney disease and deep learning are two different approaches in the field of machine learning. In this study, image omics and deep learning were used to analyze the images. Image omics extracts traditional image features, including shape, gray scale, texture, etc., and uses machine learning (pattern recognition) models to classify and predict, such as support vector machine, random forest, XGBoost, etc. Deep learning directly uses the convolutional network CNN to extract features, and completes classification and prediction in combination with the full connection layer, etc. This study aims to explore the detection of diabetic kidney disease and its pathological degree based on automatic segmentation ultraound-based radiomics technology, mining of internal information of ultrasound images, and form a set of non-invasive monitoring of diabetic kidney disease complications development system, especially in primary medical institutions, has a broad clinical application prospect.

Interventions

DIAGNOSTIC_TESTultrasonic imaging

Two-dimensional ultrasound images of the patient's kidneys were obtained by ultrasound imaging.

Sponsors

Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* patients with clinical diagnosis of T2DM and DKD were enrolled. * patients with clear B mode ultrasound imaging in both side of kidney (left and right). * No missing value in the vital clinical data such as eGFR and UACR.

Exclusion criteria

* Patients with large kidney space occupying disease such as kidney renal cyst and tumor were excluded. * Ultrasound images with severe shadow or incomplete kidney border were excluded.

Design outcomes

Primary

MeasureTime frameDescription
AUC6 monthsThe area under curve (AUC) of radiomics model for differentiating DKD and T2DM or high level and low level DKD patients

Secondary

MeasureTime frameDescription
Miou6 monthsThe mean intersection over union (Miou) of DL-based auto-segmentation in different medical centers
mPA6 monthsThe mean pixel accuracy (mPA) of DL-based auto-segmentation in different medical centers

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026